MFH yields 35.40% · PFE yields 6.13%● Live data
📍 MFH pulled ahead of the other in Year 1
Combined, MFH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MFH + PFE for your $10,000?
Mercurity Fintech Holding Inc. engages in the design, development, creation, testing, installation, configuration, integration, and customization of operational software based on blockchain technologies and related services in the British Virgin Islands and the Asia pacific region. It provides digital asset trading infrastructure solutions based on internet and blockchain technologies for cryptocurrency traders, blockchain-based virtual communities, and liquidity providers.; an asset digitalization platform, which provides blockchain-based digitalization solutions for traditional assets, such as fiat currencies, bonds, and precious metals. The company also offers a decentralized finance platform that solves retail traders' problems; cross-border payments services; and supplemental services for its platforms, such as customized software development, maintenance, and compliance support services. In addition, it provides blockchain technology services, which includes designing and developing digital asset transaction platforms, digital asset quantitative investment software, and other innovative and derivative services based on blockchain technologies; and cryptocurrency mining services that provides computing power to the mining pool. The company was formerly known as JMU Limited and changed its name to Mercurity Fintech Holding Inc. in April 2020. Mercurity Fintech Holding Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.
Full MFH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.